Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic β-cells from apoptosis

Human Gene Therapy

Volumn 7, Issue 14, 1996, Pages 1719-1726

  Liu, Yingxian ^a   Rabinovitch, Alex ^b   Suarez Pinzon, Wilma ^b   Muhkerjee, Bhaskar ^a   Brownlee, Michael ^a   Edelstein, Diane ^a   Federoff, Howard J ^a,c,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA FRAGMENT; INSULIN; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INSULIN RELEASE; MOUSE; NONHUMAN; ONCOGENE; PANCREAS ISLET BETA CELL; PROMOTER REGION; RECOMBINANT GENE; REPORTER GENE; VIRUS GENE;

ANIMALIA; ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1; MURINAE;

EID: 0029801229     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.14-1719     Document Type: Article

References (48)

1. ALLSOPP, T., WYATT, S., PATTERSON, H., and DAVIES, A. (1993). The proto-oncogene bcl-2 can selectively rescue neurotrophic factor dependent neurons from apoptosis. Cell 73, 295-307.
2. ALMEMRI, E., ROBERTSON, N., FERNANDEZ, T., CROCE, C., and LITWACK, G. (1992). Overexpressed full-length human Bcl-2 extends survival of baculovirus-infected SF9 insect cells. Proc. Natl. Acad. Sci. USA 89, 7295-7299.
3. ANDERSEN, J., GARBER, D., MEANEY, C., and BREAKEFIELD, X. (1992). Gene transfer into mammalian central nervous system using herpes virus vectors: Extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter. Hum. Gene Ther. 3, 487-499.
4. NGFR defines high-affinity NGF binding. J. Neurosci. 13, 941-951.
5. BEHL, C., HOVEY, L.I., KRAJEWSKI, S., SCHUBERT, D., and REED, J. (1993). Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Comm. 197, 949-956.
6. BERGOLD, P., CASSACCIA-BONNEFIL, P., XIU-LIU, Z., and FEDEROFF, H.J. (1993). Transynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc. Natl. Acad. Sci. USA 90, 6165-6169.
7. BERKE, G. (1994). The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12, 735-773.
8. BOOTHMAN, D.A., GELLER, A.I., and PARDEE, A.B. (1989). Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells. FEBS Lett. 258, 159-162.
9. CHIU, V.K., WALSH, C.M., LIU, C.C., REED, J.C., and CLARK, W.R. (1995). Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J. Immunol. 154, 2023-2032.
10. CLAYTON, H., JAMES, R., and LONDON, N. (1993). Islet microencapsulation. Acta Diabetologia 30, 181-189.
11. COLE, D., WATERFALL, M., McINTYRE, M., and BAIRD, J. (1992). Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 35, 231-237.
12. CORBETT, J., SWEETLAND, M., WANG, J., LANCASTER, J.J., and McDANIEL, M. (1993). Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of langerhans. Proc. Natl. Acad. Sci. USA 90, 1731-1735.
13. D'AMBRA, R., SURANA, M., EFRAT, S., STARR, R., and FLEISCHER, N. (1990). Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells. Endocrinology 126, 2815-2822.
14. DOBSON, A., MARGOLIS, T.P., SEDARATI, F., STEVENS, J., and FELDMAN, L.T. (1990). A latent, nonpathogenic HSV-1 derived vector stably expresses Beta-galactosidase in mouse neurons. Neuron 5, 353-360.
15. EFRAT, S., LINDE, S., KOFOD, H., SPECTOR, D., DELANNOY, M., GRANT, S., HANAHAN, D., and BAEKKESKOV, S. (1988). Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA 85, 9037-9041.
16. EISENBARTH, G., and KAHN, C. (1990). In Etiology and Pathogenesis of Diabetes Mellitus. K. Becker, ed. (JB Lippincott, Philadelphia), pp. 1074-1084.
17. EIZIRIK, D., SANDLER, K., WELSH, N., CETKOVIC-CVRLJE, NIEMAN, A., GELLER, D., PIPELEERS, D., BENDTZEN, K., and HELLERSTROM, C. (1994). Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93, 1968-1974.
18. FEDEROFF, H.J. (1997). Growth of replication defective herpes virus amplicon vectors and their use for gene transfer. In Cell Biology Manual. D. Spector, L. Leinwand, and R. Goldman, ed. (Cold Spring Harbor Press, Cold Spring Harbor, NY) in press.
19. FEDEROFF, H.J., GESCHWIND, M.D., GELLER, A.I., and KESSLER, J.A. (1992). Expression of nerve growth factor in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89, 1636-1640.
20. GELLER, A.I., and BREAKEFIELD, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241, 1667-1669.
21. GELLER, A.I., and FREESE, A. (1990). Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase. Proc. Natl. Acad. Sci. USA 87, 1149-1153.
22. GESCHWIND, M., KESSLER, J., GELLER, A., and FEDEROFF, H.J. (1994a). Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective Herpes Simplex virus vector. Mol. Brain Res. 24, 327-335.
23. GESCHWIND, M., LU, B., and FEDEROFF, H.J. (1994b). In Expression of neurotrophic genes from HSV-1 vectors: Modifying neuronal phenotype. Viral Transfection of Intrinsic Cells Within the Brain. P. Conn, ed. (Academic Press, Inc., Orlando, Florida), vol. 21.
24. GOTOH, M., MAKI, J., KIYOIZUMI, T., SATOMI, S., and MONACO, A.P. (1985). An improved method for isolation of mouse pancreatic islets. Transplantation 40, 437-438.
25. IWAHASHI, H., HANAFUSA, T., EGUCHI, Y., NAKAJIMA, H., ITOH, N., TOMITA, K., NAMBA, M., KUWAJIMA, M., NOGUCHI, T., TSUJIMOTO, Y., and MATSUZAWA, Y. (1996). Cytokine-induced apoptotic cells death in a mouse pancreatic beta-cell line: Inhibtion by Bcl-2. Diabetologia 39, 530-536.
26. HELLERSTROM, C. (1984). The story of the pancreatic β-Cell. Diabetologia 26, 393-400.
27. ITOH, N., TSUJIMOTO, Y., and NAGATA, S. (1993). Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621-627.
28. JAATTELA, M., BENEDICT, M., TEWARI, M., SHAYMAN, J.A., and DIXIT (1995). Bcl-x ad Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10, 2297-2305.
29. JOHNSON, P., MIYANOHARA, A., LEVINE, F., CAHILL, T., and FRIEDMANN, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type I. J. Virol. 66, 2952-2965.
30. LACRONIQUE, V., MIGNON, A., FABRE, M., VIOLELET, B., ROUQUET, N., MOLINA, T., PORTEU, A., HENRION, A., BOUSCARY, D., VARLET, P., JOULIN, V., and KAHN, A. (1996). Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med. 2, 80-86.
31. LACY, P., and KOSTIANOVSKY, M. (1967). Method for the isolation of intact islets of langerhans from the rat pancreas. Diabetes 16, 35-39.
32. LEIST, M., GANTNER, F., BOHLINGER, I., GERMAN, P., TIEGS, G., and WENDEL, A. (1994). Murine hepatocyte apoptosis induced in vitro and in vivo by TNFα requires transcriptional arrest. J. Immunol. 153, 1778-1788.
33. LU, B., and FEDEROFF, H.J. (1995). Herpes simplex virus type-1 amplicon vectors with glucocorticoid inducible gene expression. Hum. Gene Ther. 6, 419-428.
34. LU, B., GUPTA, S., and FEDEROFF, H.J. (1995). Ex vivo hepatic gene transfer using a defective herpes simplex viral vector. Hepatology 21, 752-759.
35. MIYANOHARA, A., JOHNSON, P., ELAM, R., DAI, Y., WITZUM, J., VERMA, I., and FRIEDMANN, T. (1992). Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol. 4, 238-246.
36. PATERSON, T., and EVERETT, R. (1990). A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J. Gen. Virol. 71, 1775-1783.
37. RABINOVITCH, A., SUAREZ-PINZON, W., SHI, Y., MORGAN, R., and BLEACKLEY, R. (1994a). DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37, 733-738.
38. RABINOVITCH, A., SUAREZ-PINZON, W., STRYNADKA, K., SCHULZ, R., LAKEY, J., WARNOCK, G., and RAJOTTE, R. (1994b). Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J. Clin. Endocrinol. Metab. 79, 1058-1062.
39. REED, J. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124, 1-6.
40. SPAETE, R., and FRENKEL, N. (1982). The herpes simplex virus amplicon: a new eukaryotic defective-virus cloning-amplifying vector. Cell 30, 305-310.
41. SPAETE, R., and FRENKEL, N. (1985). The herpes simplex virus amplicon: Analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82, 694-698.
42. STADLER, T., SINUHE, H., and ERB, P. (1994). Fas antigen is the major target molecule for CD4 T cell-mediated cytotoxicity. J. Immunol. 152, 1127-1133.
43. STOW, N., and McMONAGLE, E. (1982). Propagation of foreign DNA sequences linked to a herpes simplex virus origin of replication. In Eukaryotic Viral Vectors. Y. Gluzman, ed. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) pp. 199-204.
44. STRASSER, A., HARRIS, A.W., HUANG, D.C., KRAMMER, P.H., and CORY, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147.
45. WEIR, J., and ELKIN, K. (1993). Replication-incompetent herpesvirus vector delivery of an interferon a gene inhibits human immunodeficiency virus replication in human monocytes. Proc. Natl. Acad. Sci. USA 90, 9140-9144.
46. WELLER, M., MALIPIERO, U., AGUZZI, A., REED, J.C., and FONTANA, A. (1995). Protooncogene bcl-2 gene transfr abrogated Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapcutic drugs and therapeutic irradiation. J. Clin. Invest. 95, 2633-2643.
47. XU, H., FEDEROFF, H.J., PARADA, L., and KESSLER, J. (1994). Transduction of the gpl4O trk gene using a defective herpes simplex virus renders cells NGF responsive. Dev. Biol. 163, 152-161.
48. ZHONG, L.-T., SARAFIAN, T., KANE, D., CHARLES, A., MAH, S., EDWARDS, R., and BREDESEN, D. (1993). Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90, 4533-4537.